Showing results (1-10 of 451) with videos related to
Sort By:
Pageof 46
Current Gastroenterology Reports|September 29, 2014
The use of prognostic factors in inflammatory bowel diseasesThomas Billiet, Marc Ferrante, Gert Van AsscheJournal of Gastroenterology|March 21, 2018
New treatment options for inflammatory bowel diseasesBram Verstockt, Marc Ferrante, Séverine Vermeire, et al.Scandinavian Journal of Gastroenterology|September 27, 2018
When IBD is not IBDBram Verstockt, Séverine Vermeire, Gert Van Assche, et al.Expert Opinion on Biological Therapy|November 8, 2016
Biological therapy targeting the IL-23/IL-17 axis in inflammatory bowel diseaseBram Verstockt, Gert Van Assche, Séverine Vermeire, et al.Expert Opinion on Drug Safety|June 3, 2017
A safety assessment of biological therapies targeting the IL-23/IL-17 axis in inflammatory bowel diseasesBram Verstockt, Barbara Deleenheer, Gert Van Assche, et al.Journal of Crohn'S & Colitis|September 4, 2016
Sarcoidosis-Like Lesions: Another Paradoxical Reaction to Anti-TNF Therapy?Amelie Decock, Gert Van Assche, Séverine Vermeire, et al.Current Gastroenterology Reports|November 12, 2009
Optimizing biologic therapies for inflammatory bowel disease (ulcerative colitis and Crohn's disease)Marc Ferrante, Geert D'Haens, Paul Rutgeerts, et al.Expert Opinion on Biological Therapy|November 12, 2013
Targeting TNF-α for the treatment of inflammatory bowel diseaseThomas Billiet, Paul Rutgeerts, Marc Ferrante, et al.Inflammatory Bowel Diseases|December 18, 2014
Aeromonas species: an opportunistic enteropathogen in patients with inflammatory bowel diseases? A single center cohort studyTriana Lobatón, Ilse Hoffman, Severine Vermeire, et al.Pageof 46